or
forgot password
  • cancer clinical trials in idaho

  • Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
    Saint Luke's Mountain States Tumor Institute

    Trial Locations
    Saint Luke's Mountain States Tumor Institute
    Saint Luke's Mountain States Tumor Institute - Fruitland
    St. Joseph Regional Medical Center
    Mountain States Tumor Institute - Meridian
    Mountain States Tumor Institute at St. Luke's
    Lung Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    St. Joseph Regional Medical Center
    Lewiston, Idaho 83501
    Kidney Cancer
    Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Leukemia
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Mountain States Tumor Institute at St. Luke's Regional Medical Center

    Trial Locations
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Saint Luke's Mountain States Tumor Institute
    Saint Luke's Mountain States Tumor Institute - Fruitland
    Mountain States Tumor Institute - Meridian
    Mountain States Tumor Institute at St. Luke's
    Colorectal Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Saint Alphonsus Regional Medical Center

    Trial Locations
    Saint Alphonsus Regional Medical Center
    Kootenai Cancer Center
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Childhood Mixed Glioma, Untreated Childhood Brain Stem Glioma
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Ovarian Clear Cell Cystadenocarcinoma, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Saint Luke's Mountain States Tumor Institute

    Trial Locations
    Saint Luke's Mountain States Tumor Institute
    Saint Luke's Mountain States Tumor Institute - Fruitland
    Saint Luke's Mountain States Tumor Institute - Meridian
    Saint Luke's Mountain States Tumor Institute - Nampa
    Saint Luke's Mountain States Tumor Institute-Twin Falls
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Recurrent Childhood Medulloblastoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
    Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

    Coeur D'alene, Idaho 83814
    Prostate Neoplasms, Genital Neoplasms, Male, Urogenital Neoplasms, Genital Diseases, Male
    Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Head and Neck Cancer
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center

    Trial Locations
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    St. Joseph Regional Medical Center
    Idaho Urologic Institute, PA
    Prostate Cancer
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    Saint Luke's Mountain States Tumor Institute

    Trial Locations
    Saint Luke's Mountain States Tumor Institute
    Saint Luke's Mountain States Tumor Institute - Fruitland
    Mountain States Tumor Institute - Meridian
    Mountain States Tumor Institute at St. Luke's
    Breast Cancer
    Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Saint Alphonsus Regional Medical Center

    Trial Locations
    Saint Alphonsus Regional Medical Center
    Saint Luke's Mountain States Tumor Institute
    Saint Luke's Mountain States Tumor Institute - Fruitland
    Saint Luke's Mountain States Tumor Institute - Meridian
    Saint Luke's Mountain States Tumor Institute - Nampa
    Saint Luke's Mountain States Tumor Institute-Twin Falls
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Saint Luke's Mountain States Tumor Institute - Fruitland

    Trial Locations
    Saint Luke's Mountain States Tumor Institute - Fruitland
    Saint Joseph Regional Medical Center
    Saint Luke's Mountain States Tumor Institute - Meridian
    Saint Luke's Mountain States Tumor Institute - Nampa
    Portneuf Medical Center
    Kootenai Cancer Center
    Saint Luke's Mountain States Tumor Institute-Twin Falls
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
    Advanced Clinical Research
    Meridian, Idaho 83642
    Overactive Bladder
    Bevacizumab With or Without Fosbretabulin Tromethamine in Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer